Cytyc to use existing facility for Adeza purchase

By Sara Rosenberg

New York, Feb. 12 - Cytyc Corp. plans to use borrowings under its existing credit facility to help fund the$452 million acquisition of Adeza Biomedical Corp., according to a company news release.

Other acquisition financing will come from Cytyc's existing cash and the cash on Adeza's balance sheet.

The acquisition will be conducted by means of a tender for all of the outstanding shares of Adeza. Completion of the tender is expected before the end of March.

Cytyc is a Marlborough, Mass., diagnostic and medical device company. Adeza is a Sunnyvale, Calif., designer, developer, manufacturer and marketer of women's health care products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.